Press Resease

Rat Model Market - Global Industry Analysis

Rat Model Market By Rat Type (Outbred, Conditioned, Knockout, and Others), Technology (Embryonic Stem Cells, Microinjection, and Others), By Service (Breeding, Quarantine, Cryopreservation, and Others), By Application (Toxicology, CNS, Oncology, Diabetes and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 19-Aug-2021 Category: Healthcare Report Format : PDF Pages: 150 Report Code: ZMR-126 Status : Published

The global Rat Model market accounted for USD 535.9 Million in 2020 and is expected to reach USD 1,166.2 Million by 2028, growing at a CAGR of 10.2% from 2021 to 2028.

Description

Market Overview      

The global Rat Model market accounted for USD 535.9 Million in 2020 and is expected to reach USD 1,166.2 Million by 2028, growing at a CAGR of 10.2% from 2021 to 2028.     

Rat model is an animal model for research in biomedical science and psycology. Rats and humans both have similarities such as physiology, similar body organs, similar genetic structure to the humans and often suffer from the same diseases.      

A rat model has been used frequently in drug development, toxicology and various biomedical fields, including carcinogenicity testing. Ongoing research for the development of treatment on neurology disorder and cancer coupled with the emergence of transgenic rat models is expected to fuel the demand of rat models in coming years. In addition, advancement in bioinformatics that leads the development of tools and software for analysis of data generated after pre-clinical research using rat models is anticipated to boost the growth of this market in coming years. However, rising concern about animal cruelty, ethical concerns as well as the threat from the advancement of zebra fish models is expected to hinder the growth of the market in the forecast period.

 COVID-19 Impact Analysis:

The global Rat Model market has witnessed a slight decrease due to the lockdown enforcement placed by various governments in order to contain COVID spreading. People had no option but to remain indoor, so the sales of instrument had decrease drastically. The restrictions imposed by various nations to contain COVID had stopped the Rat model resulting in a disruption across the whole supply chain. However, the world markets are slowly opening to their full potential and theirs a surge in demand. The market would remain bullish in upcoming year.    

Global Rat Model Market Size

Growth Factors

Major boosting factors for Rat Model market are increasing non-government and government initiatives for fetal & maternal health all over the world, as per the analysts at Zion Market Research. In addition to this, rising awareness of manufacturers and willingness of players to spend in the development of fetal monitoring is also powering the development of Rat Model market. Moreover, enhanced models that assist to calculate the maternal parameters such as maternal heart rate, and blood pressure are also likely to fuel the development of Rat Model market in coming years. On the other hand, lack of intervening guidelines and technological challenges might hamper the development of the global Rat Model market in the years to come.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Segment Analysis Preview  

On the basis of Rat Types, the Rat Model market is likely to be ruled by Outbred segment. The extensive use of outbred rats in toxicology and safety assessment studies is expected to drive the growth of rat model in coming year.  

Depending on Technology, Embryonic Stem Cells segment is likely to hold the major share in the market and is anticipated to remain dominant throughout the forecast period. This is attributed to the ongoing developments of alternative methods to animal testing.

On the basis of application, Oncology segment hold the majority of Rat Model market share 2020.

Global Rat Model Market Share

Region Analysis Preview  

North America was the dominating regional market for rat model and further it would follow this trend in forecast period due to robust research activities. Europe held the second largest market share and Germany acquired the largest share in this region in 2020. An increasing number of academic and contract research organizations is the major driving factors of rat model in Asia Pacific region.  

Key Market Players & Competitive Landscape

Some of key players in Rat Model Market are Covance, Inc., Transviragen Inc., SAGE Labs, Biomedical Research Models, Inc., genOway S.A., Transposagen Biopharmaceuticals, Harlan Laboratories, Inc and Charles River Laboratories amongst others.  

Global Rat Model Market Regional Analysis

The global Rat Model Market is segmented as follows:   

By Rat Type

  • Outbred
  • Conditioned
  • Knockout
  • Others

By Technology

  • Embryonic Stem Cells
  • Microinjection
  • Others

By Service

  • Breeding
  • Quarantine
  • Cryopreservation
  • Others

By Application

  • Toxicology
  • CNS
  • Oncology
  • Diabetes
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Rat Type
        • 2.1.1.2. Market Attractiveness Analysis, By Technology
        • 2.1.1.3. Market Attractiveness Analysis, By Service
        • 2.1.1.4. Market Attractiveness Analysis, By Application
        • 2.1.1.5. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Rat Model Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Rat Model Market – Rat Type Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Rat Type, 2020 & 2028
    • 4.2. Outbred
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Conditioned
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Knockout
      • 4.4.1. Market Size and Forecast, By Region (USD Million)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Others
      • 4.5.1. Market Size and Forecast, By Region (USD Million)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Rat Model Market – Technology Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Technology, 2020 & 2028
    • 5.2. Embryonic Stem Cells
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Microinjection
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Others
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Rat Model Market – Service Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Service, 2020 & 2028
    • 6.2. Breeding
      • 6.2.1. Market Size and Forecast, By Region (USD Million)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Quarantine
      • 6.3.1. Market Size and Forecast, By Region (USD Million)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Cryopreservation
      • 6.4.1. Market Size and Forecast, By Region (USD Million)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.5. Others
      • 6.5.1. Market Size and Forecast, By Region (USD Million)
      • 6.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7 Rat Model Market – Application Segment Analysis
    • 7.1. Overview
      • 7.1.1. Market Revenue Share, By Service, 2020 & 2028
    • 7.2. Toxiculogy
      • 7.2.1. Market Size and Forecast, By Region (USD Million)
      • 7.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 7.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 7.3. CNS
      • 7.3.1. Market Size and Forecast, By Region (USD Million)
      • 7.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 7.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 7.4. Onculogy
      • 7.4.1. Market Size and Forecast, By Region (USD Million)
      • 7.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 7.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 7.5. Diabetes
      • 7.5.1. Market Size and Forecast, By Region (USD Million)
      • 7.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 7.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 7.6. Others
      • 7.6.1. Market Size and Forecast, By Region (USD Million)
      • 7.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 7.6.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 8 Rat Model Market – Regional Analysis
    • 8.1. Overview
      • 8.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 8.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 8.2. North America
      • 8.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 8.2.2. North America Market Revenue, By Rat Type, 2016 – 2028
      • 8.2.3. North America Market Revenue, By Technology, 2016 – 2028
      • 8.2.4. North America Market Revenue, By Service, 2016 – 2028
      • 8.2.5. North America Market Revenue, By Application, 2016 – 2028
      • 8.2.6. U.S.
        • 8.2.6.1. U.S. Market Revenue, By Rat Type, 2016 – 2028
        • 8.2.6.2. U.S. Market Revenue, By Technology, 2016 – 2028
        • 8.2.6.3. U.S. Market Revenue, By Service, 2016 – 2028
        • 8.2.6.4. U.S. Market Revenue, By Application, 2016 – 2028
      • 8.2.7. Canada
        • 8.2.7.1. Canada Market Revenue, By Rat Type, 2016 – 2028
        • 8.2.7.2. Canada Market Revenue, By Technology, 2016 – 2028
        • 8.2.7.3. Canada Market Revenue, By Service, 2016 – 2028
        • 8.2.7.4. Canada Market Revenue, By Application, 2016 – 2028
      • 8.2.8. Mexico
        • 8.2.8.1. Mexico Market Revenue, By Rat Type, 2016 – 2028
        • 8.2.8.2. Mexico Market Revenue, By Technology, 2016 – 2028
        • 8.2.8.3. Mexico Market Revenue, By Service, 2016 – 2028
        • 8.2.8.4. Mexico Market Revenue, By Application, 2016 – 2028
    • 8.3. Europe
      • 8.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 8.3.2. Europe Market Revenue, By Rat Type, 2016 – 2028
      • 8.3.3. Europe Market Revenue, By Technology, 2016 – 2028
      • 8.3.4. Europe Market Revenue, By Service, 2016 – 2028
      • 8.3.5. Europe Market Revenue, By Application, 2016 – 2028
      • 8.3.6. Germany
        • 8.3.6.1. Germany Market Revenue, By Rat Type, 2016 – 2028
        • 8.3.6.2. Germany Market Revenue, By Technology, 2016 – 2028
        • 8.3.6.3. Germany Market Revenue, By Service, 2016 – 2028
        • 8.3.6.4. Germany Market Revenue, By Application, 2016 – 2028
      • 8.3.7. France
        • 8.3.7.1. France Market Revenue, By Rat Type, 2016 – 2028
        • 8.3.7.2. France Market Revenue, By Technology, 2016 – 2028
        • 8.3.7.3. France Market Revenue, By Service, 2016 – 2028
        • 8.3.7.4. France Market Revenue, By Application, 2016 – 2028
      • 8.3.8. U.K.
        • 8.3.8.1. U.K. Market Revenue, By Rat Type, 2016 – 2028
        • 8.3.8.2. U.K. Market Revenue, By Technology, 2016 – 2028
        • 8.3.8.3. U.K. Market Revenue, By Service, 2016 – 2028
        • 8.3.8.4. U.K. Market Revenue, By Application, 2016 – 2028
      • 8.3.9. Italy
        • 8.3.9.1. Italy Market Revenue, By Rat Type, 2016 – 2028
        • 8.3.9.2. Italy Market Revenue, By Technology, 2016 – 2028
        • 8.3.9.3. Italy Market Revenue, By Service, 2016 – 2028
        • 8.3.9.4. Italy Market Revenue, By Application, 2016 – 2028
      • 8.3.10. Spain
        • 8.3.10.1. Spain Market Revenue, By Rat Type, 2016 – 2028
        • 8.3.10.2. Spain Market Revenue, By Technology, 2016 – 2028
        • 8.3.10.3. Spain Market Revenue, By Service, 2016 – 2028
        • 8.3.10.4. Spain Market Revenue, By Application, 2016 – 2028
      • 8.3.11. Rest of Europe
        • 8.3.11.1. Rest of Europe Market Revenue, By Rat Type, 2016 – 2028
        • 8.3.11.2. Rest of Europe Market Revenue, By Technology, 2016 – 2028
        • 8.3.11.3. Rest of Europe Market Revenue, By Service, 2016 – 2028
        • 8.3.11.4. Rest of Europe Market Revenue, By Application, 2016 – 2028
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 8.4.2. Asia Pacific Market Revenue, By Rat Type, 2016 – 2028
      • 8.4.3. Asia Pacific Market Revenue, By Technology, 2016 – 2028
      • 8.4.4. Asia Pacific Market Revenue, By Service, 2016 – 2028
      • 8.4.5. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 8.4.5. China
        • 8.4.5.1. China Market Revenue, By Rat Type, 2016 – 2028
        • 8.4.5.2. China Market Revenue, By Technology, 2016 – 2028
        • 8.4.5.3. China Market Revenue, By Service, 2016 – 2028
        • 8.4.5.4. China Market Revenue, By Application, 2016 – 2028
      • 8.4.6. Japan
        • 8.4.6.1. Japan Market Revenue, By Rat Type, 2016 – 2028
        • 8.4.6.2. Japan Market Revenue, By Technology, 2016 – 2028
        • 8.4.6.3. Japan Market Revenue, By Service, 2016 – 2028
        • 8.4.6.4. Japan Market Revenue, By Application, 2016 – 2028
      • 8.4.7. India
        • 8.4.7.1. India Market Revenue, By Rat Type, 2016 – 2028
        • 8.4.7.2. India Market Revenue, By Technology, 2016 – 2028
        • 8.4.7.3. India Market Revenue, By Service, 2016 – 2028
        • 8.4.7.4. India Market Revenue, By Application, 2016 – 2028
      • 8.4.8. South Korea
        • 8.4.8.1. South Korea Market Revenue, By Rat Type, 2016 – 2028
        • 8.4.8.2. South Korea Market Revenue, By Technology, 2016 – 2028
        • 8.4.8.3. South Korea Market Revenue, By Service, 2016 – 2028
        • 8.4.8.4. South Korea Market Revenue, By Application, 2016 – 2028
      • 8.4.9. South-East Asia
        • 8.4.9.1. South-East Asia Market Revenue, By Rat Type, 2016 – 2028
        • 8.4.9.2. South-East Asia Market Revenue, By Technology, 2016 – 2028
        • 8.4.9.3. South-East Asia Market Revenue, By Service, 2016 – 2028
        • 8.4.9.4. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 8.4.10. Rest of Asia Pacific
        • 8.4.10.1. Rest of Asia Pacific Market Revenue, By Rat Type, 2016 – 2028
        • 8.4.10.2. Rest of Asia Pacific Market Revenue, By Technology, 2016 – 2028
        • 8.4.10.3. Rest of Asia Pacific Market Revenue, By Service, 2016 – 2028
        • 8.4.10.4. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 8.5. Latin America
      • 8.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 8.5.2. Latin America Market Revenue, By Rat Type, 2016 – 2028
      • 8.5.3. Latin America Market Revenue, By Technology, 2016 – 2028
      • 8.5.4. Latin America Market Revenue, By Service, 2016 – 2028
      • 8.5.5. Latin America Market Revenue, By Application, 2016 – 2028
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Market Revenue, By Rat Type, 2016 – 2028
        • 8.5.5.2. Brazil Market Revenue, By Technology, 2016 – 2028
        • 8.5.5.3. Brazil Market Revenue, By Service, 2016 – 2028
        • 8.5.5.4. Brazil Market Revenue, By Application, 2016 – 2028
      • 8.5.6. Argentina
        • 8.5.6.1. Argentina Market Revenue, By Rat Type, 2016 – 2028
        • 8.5.6.2. Argentina Market Revenue, By Technology, 2016 – 2028
        • 8.5.6.3. Argentina Market Revenue, By Service, 2016 – 2028
        • 8.5.6.4. Argentina Market Revenue, By Application, 2016 – 2028
      • 8.5.7. Rest of Latin America
        • 8.5.7.1. Rest of Latin America Market Revenue, By Rat Type, 2016 – 2028
        • 8.5.7.2. Rest of Latin America Market Revenue, By Technology, 2016 – 2028
        • 8.5.7.3. Rest of Latin America Market Revenue, By Service, 2016 – 2028
        • 8.5.7.4. Rest of Latin America Market Revenue, By Application, 2016 – 2028
    • 8.6. The Middle-East and Africa
      • 8.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 8.6.2. The Middle-East and Africa Market Revenue, By Rat Type, 2016 – 2028
      • 8.6.3. The Middle-East and Africa Market Revenue, By Technology, 2016 – 2028
      • 8.6.4. The Middle-East and Africa Market Revenue, By Service, 2016 – 2028
      • 8.6.5. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 8.6.5. GCC Countries
        • 8.6.5.1. GCC Countries Market Revenue, By Rat Type, 2016 – 2028
        • 8.6.5.2. GCC Countries Market Revenue, By Technology, 2016 – 2028
        • 8.6.5.3. GCC Countries Market Revenue, By Service, 2016 – 2028
        • 8.6.5.4. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 8.6.6. South Africa
        • 8.6.6.1. South Africa Market Revenue, By Rat Type, 2016 – 2028
        • 8.6.6.2. South Africa Market Revenue, By Technology, 2016 – 2028
        • 8.6.6.3. South Africa Market Revenue, By Service, 2016 – 2028
        • 8.6.6.4. South Africa Market Revenue, By Application, 2016 – 2028
      • 8.6.7. Rest of Middle-East Africa
        • 8.6.7.1. Rest of Middle-East Africa Market Revenue, By Rat Type, 2016 – 2028
        • 8.6.7.2. Rest of Middle-East Africa Market Revenue, By Technology, 2016 – 2028
        • 8.6.7.3. Rest of Middle-East Africa Market Revenue, By Service, 2016 – 2028
        • 8.6.7.4. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
  • Chapter No. 8 Rat Model Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Service Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9 Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Rat Model Market: Company Market Share, 2019
      • 9.1.2. Global Rat Model Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 9.1.3. Global Rat Model Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Rat Model Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Rat Type Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10 Company Profiles
    • 10.1. Covance, Inc
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfolio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. Transviragen Inc
    • 10.3. SAGE Labs
    • 10.4. Biomedical Research Models, Inc
    • 10.5. genOway S.A
    • 10.6. Transposagen Biopharmaceuticals
    • 10.7. Harlan Laboratories
    • 10.8. Charles River Laboratories
  • Chapter No. 11 Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Environmental Change
  • Chapter No. 12 Research Methodology
    • 12.1. Research Methodology
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Rat Model market. Zion Research has collected and analyzed key data belong to the global Rat Model market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined afterconducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Rat Model across the world has been calculated through primary and secondary research.

Zion Research employs combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include, STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assistedin validation of findings from secondary research and to understand key trends in the Rat Model industry. Primary research makes up major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Rat Model market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

The process of research with the help of rat to detect human mechanisms underlying human disease progress is called as rat model. The rat model is used by researcher due to the capability of rats to elucidate human disease processes. In addition, there is a lot of similarity between the genetics, physiology, and anatomy of rats and human. For hypertension and cardiovascular diseases, rat model is considered as an ideal model. Finger nucleases have enabled the generation of economically and technically feasible transgenic rat models.

The growth of rat model markets is primarily driven by continuous research practices undertaken to develop treatments for neurology disorders and cancer. In addition, the emergence of transgenic rat models coupled with advancement in bioinformatics which allow development of software and tools for analysis of data generated after pre-clinical research using rat models is anticipated to boost the growth of rat model in coming years. However, rising concern about animal cruelty coupled advancement in zebrafish models is expected to have the adverse impact on rat model market. Nonetheless, an initiative of government for investments and grants is likely to disclose new avenues for rat model market in the near future.

Global Rat Model Market

Outbred rat, conditioned rat, knockout rat and others rat are the type segments of rat model market. Outbred rat emerged as the largest segment in term of market share in 2015. This growth is attributed to extensive use of outbred rats in toxicology.

Service segment includes breeding, quarantine, cryopreservation and others. Breeding services acquired the largest market share in 2015 and expected to grow with highest CAGR during the forecast period. Cryopreservation service is expected to experience significant growth in coming years. Embryonic stem cells, microinjection, and others are the technology segment of rat model market.

Based on the various applications, the global rat model market is segmented into toxicology, oncology, CNS, immunology and inflammation, diabetes and other diseases segments. Oncology and toxicology segment are expected to experience significant growth in coming years as a consequence of rising incidences of different types of cancers.

Geographically, rat model market is dominated by North America followed by Europe. Government initiatives and funding for research activities are further expected to boost the market growth in these regions over the forecast period. Moreover, rat model market has a huge opportunity in the emerging markets of Asia Pacific due to increasing population.

The key player of this market includes Covance, Inc., Transviragen Inc ., SAGE Labs, Biomedical Research Models, Inc., genOway S.A., Transposagen Biopharmaceuticals, Harlan Laboratories, Inc and Charles River Laboratories amongst others.


Frequently Asked Questions

The global Rat Model Market was valued at USD 535.9 Million in 2020.

The global Rat Model Market is expected to reach USD 1,166.2 Million by 2028, growing at a CAGR of 10.2% between 2021 to 2028.

Some of the key factors driving the global Rat Model Market growth are extensive use of outbred rats in toxicology and safety assessment studies, and  advancement in bioinformatics that leads the development of tools and software for analysis of data generated after pre-clinical research using rat models.

N North America was the dominating regional market for rat model and further it would follow this trend in forecast period due to robust research activities. Europe held the second largest market share and Germany acquired the largest share in this region in 2020. An increasing number of academic and contract research organizations is the major driving factors of rat model in Asia Pacific region.  

Some of the major companies operating in Rat Model Market are Covance, Inc., Transviragen Inc., SAGE Labs, Biomedical Research Models, Inc., genOway S.A., Transposagen Biopharmaceuticals, Harlan Laboratories, Inc and Charles River Laboratories amongst others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social